|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20062476
Ørsted et al. • Figure S1 Timeline of the Copenhagen City Heart Study.
• Figure S2 Frequency of P53 Arg72Pro genotypes a as function of age in 5-yr groups.
• Figure S3 Frequency of the P53 Arg72Pro Pro allele and fraction of deaths as a function of age in 5-yr groups.
• Figure S4 P53 Arg72Pro genotype and risk of death and death after a cancer diagnosis after stratification for genetic variation in ATM and MDM2 genes.
• Figure S5 Arg72Pro genotype associated with risk of cancer and cancer subgroups.
• Table S1 Mortality after disease and morbidity according to p53 Arg72Pro genotype in the general population
• Table S2 Mortality after cancer subgroups according to low, middle, and high p53 somatic mutation frequencies and p53 Arg72Pro germline genotype in the general population
| ||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
